SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hisae Iinuma, Ryoji Fukushima, Tsuyoshi Inaba, Junko Tamura, Taisuke Inoue, Etsushi Ogawa, Masahiro Horikawa, Yoshibumi Ikeda, Noriyuki Matsutani, Kazuyoshi Takeda, Koji Yoshida, Takuya Tsunoda, Tadashi Ikeda, Yusuke Nakamura, Kota Okinaga, Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients, Journal of Translational Medicine, 2014, 12, 1, 84

    CrossRef

  2. 2
    Y. Diaz, Y. Tundidor, A. Lopez, K. Leon, Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response, Cancer Immunology, Immunotherapy, 2013, 62, 3, 455

    CrossRef

  3. 3
    Akira Yamada, Tetsuro Sasada, Masanori Noguchi, Kyogo Itoh, Next-generation peptide vaccines for advanced cancer, Cancer Science, 2013, 104, 1
  4. 4
    Masanori Noguchi, Tetsuro Sasada, Kyogo Itoh, Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine, Cancer Immunology, Immunotherapy, 2013, 62, 5, 919

    CrossRef

  5. 5
    Vanessa Deschoolmeester, Evelien Smits, Marc Peeters, Jan B. Vermorken, Status of Active Specific Immunotherapy for Stage II, Stage III, and Resected Stage IV Colon Cancer, Current Colorectal Cancer Reports, 2013, 9, 4, 380

    CrossRef

  6. 6
    Erika Vacchelli, Isabelle Martins, Alexander Eggermont, Wolf Hervé Fridman, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial watch, OncoImmunology, 2012, 1, 9, 1557

    CrossRef

  7. 7
    Frank M Speetjens, Eliane CM Zeestraten, Peter JK Kuppen, Cornelis JM Melief, Sjoerd H van der Burg, Colorectal cancer vaccines in clinical trials, Expert Review of Vaccines, 2011, 10, 6, 899

    CrossRef

  8. 8
    Natasja K van den Engel, Dominik Rüttinger, Margareta Rusan, Robert Kammerer, Wolfgang Zimmermann, Rudolf A Hatz, Hauke Winter, Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer, Journal of Translational Medicine, 2011, 9, 1, 140

    CrossRef

  9. 9
    Vaios Karanikas, Anastasios Germenis, Determinants of cancer immunotherapy success, Expert Review of Vaccines, 2010, 9, 12, 1363

    CrossRef

  10. 10
    James L. Frazier, James E. Han, Michael Lim, Alessandro Olivi, Immunotherapy Combined with Chemotherapy in the Treatment of Tumors, Neurosurgery Clinics of North America, 2010, 21, 1, 187

    CrossRef

  11. 11
    Masanori Noguchi, Personalized peptide vaccination for urological cancer, Drug Delivery System, 2010, 25, 2, 103

    CrossRef

  12. 12
    Amedeo Amedei, Elena Niccolai, Chiara Della Bella, Fabio Cianchi, Giacomo Trallori, Marisa Benagiano, Lapo Bencini, Marco Bernini, Marco Farsi, Renato Moretti, Gianfranco Del Prete, Mario Milco D’Elios, Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma, Cancer Immunology, Immunotherapy, 2009, 58, 11, 1819

    CrossRef

  13. 13
    Tianqian Zhang, Dorothee Herlyn, Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer, Cancer Immunology, Immunotherapy, 2009, 58, 4, 475

    CrossRef

  14. 14
    Takashi Hattori, Takashi Mine, Nobukazu Komatsu, Akira Yamada, Kyogo Itoh, Hitoshi Shiozaki, Kiyotaka Okuno, Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients, Cancer Immunology, Immunotherapy, 2009, 58, 11, 1843

    CrossRef

  15. 15
    Dirk Nagorsen, Eckhard Thiel, HLA typing demands for peptide-based anti-cancer vaccine, Cancer Immunology, Immunotherapy, 2008, 57, 12, 1903

    CrossRef